Assessment of Glycemic Control in Dialysis Patients with Diabetes
Open Access
- 1 July 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 6 (7), 1520-1522
- https://doi.org/10.2215/cjn.04210511
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Glycated Albumin and Risk of Death and Hospitalizations in Diabetic Dialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- Comparison of Glycated Albumin and Hemoglobin A1c Concentrations in Diabetic Subjects on Peritoneal and HemodialysisPeritoneal Dialysis International, 2010
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysisKidney International, 2008
- Glycated Albumin Is a Better Glycemic Indicator than Glycated Hemoglobin Values in Hemodialysis Patients with DiabetesJournal of the American Society of Nephrology, 2007
- Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing HemodialysisThe New England Journal of Medicine, 2005
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993